Next 10 |
home / stock / bprmf / bprmf news
UiPath is one of the leading pure-play robotics process automation companies. It reported pretty decent results for FQ4. But it failed to convince investors. We think structural headwinds could be at play. We discuss why we revise our rating from Buy to Hold. For further det...
UiPath is the global leader in the robotic process automation market. The market is expected to grow rapidly through 2030. Its stock has fallen 44% from its May all-time high. Despite that, UiPath stock is still being priced at a premium to its peers. We discuss the company's pros...
Blue Prism is a relatively small player in enterprise software but its performance metrics point to a decent product with high customer satisfaction. A US listing looks off the cards but we believe the company would be an attractive asset for private equity funds. On the basis tha...
UiPath is a leader in the rapidly growing RPA market, potentially presenting investors with an attractive opportunity. The transition to the cloud is a question mark for UiPath though, with Automation Anywhere a particularly strong competitor in the cloud. Microsoft is increasing ...
With more scale, UiPath has been growing much faster than peers and this should continue judging by its strong recurring revenue model and growth drivers. Better growth is augmented by superior gross margins and efficiency metrics, but the company currently operates at a loss. A r...
UiPath is one of the fastest growing software companies ever and has one of the best financial metrics within the SaaS Industry. UiPath is a company on a mission to automate all forms of mundane tasks within the modern enterprise. The company has a tremendous amount of potential a...
We upgrade Alteryx from bearish to neutral with the shares correcting 32% since January 2021. Q1 FY12/2021 performance metrics were not great, but there are some signs of management laying the groundwork for success longer term. The shares look fairly valued on a current Price to ...
Unicorn stock UiPath (PATH) is extending its rally to a second day Thursday following the company’s strong initial public offering, rising as much as 15.9% intraday to take the stock more than 40% above its IPO price.PATH soared to as high as $80 a share Thursday -- up 42.9% from the $...
Unicorn stock UiPath (PATH) is set to begin trading Wednesday after the firm’s IPO priced at $56 a share, valuing the company at some $29B and beating the offering’s upsized $52-$54 price range.UiPath, which specializes in robotic process automation (or “RPA”), sai...
Our initial investment conclusion still stands - buy Blue Prism before the UiPath IPO. We had to recalibrate our view on Blue Prism in terms of market positioning versus market leader UiPath given recent events. Placing what we believe to be a 50% discount to UiPath's current Pric...
News, Short Squeeze, Breakout and More Instantly...
It can be tricky investing in international stocks. Occasionally you might find a foreign company that is nice enough to trade on one of our stock exchanges. Singapore e-commerce and gaming company Sea Limited (NYSE: SE) , for instance, sells its shares on the New York Stock ...
Hong Kong, China--(Newsfile Corp. - May 12, 2020) - Pactera and Blue Prism (OTC Pink: BPRMF) today jointly announced an alliance via the Blue Prism Partner Engage program to bring robotic process automation (RPA) solutions to clients in the Asia and Oceania region. The two organizations h...
Many small-cap stocks (stocks in companies with a market capitalization between $300 million and $2 billion) are dangerous and exciting investments. They're dangerous because they are often underfollowed and not many people have heard of them. That's also what makes them exciting -- early inve...